Relapsed/refractory T-cell Acute Lymphoblastic Leukemia research hub

A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

This study is for adults with a type of blood cancer called T-cell Acute Lymphoblastic Leukaemia (T-ALL) that has come back or not responded to previous treatments. It's testing new ways to use medicines to fight the cancer more effectively.